CD9 Antikörper (full length)
Kurzübersicht für CD9 Antikörper (full length) (ABIN7877970)
Target
Alle CD9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- CD9 Antibody
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the CD9 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Titering of the CD9 antibody may be required for optimal performance.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the CD9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- CD9
-
Andere Bezeichnung
- CD9
-
Hintergrund
- CD9 is a type IV transmembrane glycoprotein with four transmembrane domains. CD9 on pre-B cells may play a role in cell-cell adhesion. In addition, CD9 may play a role in signal transduction mediated by interaction with low molecular weight GTP binding proteins. CD9 is expressed on early B cells, eosinophils, basophils and activated T cells and is a major component of the platelet cell surface. It is also expressed on most non-T acute lymphoblastic leukemia cells and on some acute myeloid and chronic lymphoid leukemias.
-
UniProt
- P21926
-
Pathways
- Response to Water Deprivation, Cell-Cell Junction Organization
Target
-